Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Power Life Sciences

Status: Not yet enrolling

Conditions: Glioblastoma

Study type: Observational

Funder types: Industry

Identifiers

NCT05728125

82966461

Details and patient eligibility

About

Historically, clinical study participation has been biased toward certain demographics. However, there is a shortage of studies that delve into the underlying factors that influence patient participation, both positively and negatively.

Several people will be invited to enroll in this study so that it may collect a variety of data about glioblastoma clinical trial experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.

The data collected from this study will be analyzed and used to improve the experiences of future glioblastoma patients who are recruited for medical trials.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient has self-identified as planning to enroll in a clinical trial
• Patient has been diagnosed with glioblastoma
• Patient is a minimum of 18 years or older

Exclusion criteria

• Patient does not understand, sign, and return consent form
• Inability to perform regular electronic reporting
• Patient is pregnant

Trial design